NEUROBO PHARMACEUTICALS INC - NRBO
Our data come from many places. We have provided this information in one convenient place from exchanges such as NYSE, NASDAQ, and CBOE. Furthermore, the short interest we provide is not sourced solely from one place. Borrow rates are subject to the supply and demand of a company's shortable stock and its overall short interest.
The short interest information we provide is reliable. Its dissemination is regulated by various government agencies. Firms are required to report short interest data to FINRA for each security twice per month.
Dark pool trades are also included in short interest data once a trade is comsummated.
Our short squeeze score is a sophisticated measure of the likelihood any given stock will experience a short squeeze compared to its peers. Short interest, short shares availability, fee and rebate rates are all part of the calculation. Our track record is good as several of our highly rated short squeeze stocks have, in fact, gone on to big gains. A short squeeze is an exceedingly rare event, however, and there is no guarantee that any of the stocks highly ranked on our list will ever experience a short squeeze.
We also offer a technical analysis stock screener to help you find stocks that meet certain technical criteria. There's a comprehensive options section, which offers intraday alerts for notable options trading activity, outsized options volume, high implied volatility and more. A comprehensive institutional holdings section provides information gleaned from quarterly SEC filings for large investors and firms. Investor sentiment, Commitment of Traders data, earnings release information, economic release information (earnings and economic calendars), and futures quotes and charts round out the information available. Much of this information is free with an anonymous account. The full data package (essentially everything on the site minus the Daily Trading Signals trading system) is available for a one-week trial for $2.95, which then renews monthly for only $9.95. Due diligence does not have to be expensive.
The trading system is a proprietary and completely original piece of work. It has been backtested to 1990 for many stocks. The basic philosophy behind it is to encourage users to maintain a large enough portfolio of quality stocks so as to not be overly penalized by a few bad trades. It does better with higher capitalized stocks. There are exceptions, of course, where micro- and small-cap stocks have done well on the system, but they are relatively less frequent. Overall the system has outperformed the market under a wide variety of conditions. Our backtesting involved a statistical technique called bootstrapping. You can read more about our trading system. Even if they don't subscribe we encourage everyone to adopt the philosophy as it is a winning one. Years of development and rigorous statistical analysis give users the confidence to trust its trading decisions.
A companion section to the Daily Trading Signals is a section called Daily Trading Ideas. This section is included with the $9.95 basic plan along with all of the data mentioned above. Our system monitors many thousands of stocks every day and generates lots of buy signals. We guarantee you will get 10 trading ideas per week with your membership. We try to choose stocks with a proven record of performance on our system. There's no guarantee, of course, that any trade will be a good one, but with consistency and good risk management we think you will be happy with the results.
This website began as a way of organizing short interest and borrow rate data for personal use, but it has become so much more. Our team is passionate about providing timely, actionable information to the public in order to help them make more money. We pride ourselves on our customer service response times and we think this is reflected in our high customer retention rate. We would love for you to join us as we work to help even out the information availability gap on Wall Street!